Recruiting NA INTERVENTIONAL 2-arm NCT05658471

Pharmacokinetics and Pharmacodynamics of Nicotine With Use of Standardized Research Electronic Cigarette (SREC) (SREC22)

Comparative Pharmacokinetics and Pharmacodynamics of Nicotine With Use of NIDA Standardized Research Electronic Cigarette (SREC) vs Usual Brand E-cigarette

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cardiovascular Risk Factors Nicotine Dependence Tobacco Toxicity

Interventions Biological Samples Over the Counter E-Cigarette (EC) Smoking-related Questionnaires Standardized Research E-Cigarette (SREC)

Updated 6 times since 2023 Last updated: Mar 19, 2025 Started: Feb 1, 2023 Primary completion: Jan 31, 2026 Completion: Jan 31, 2026

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Cardiovascular Risk Factors and Nicotine Dependence and is currently actively recruiting participants. National Institute on Drug Abuse (NIDA) leads this study, which shows 6 recorded versions since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

6 versions recorded

Apr 2025 — Present [monthly]

Recruiting NA
Sep 2024 — Apr 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA
Apr 2024 — Jul 2024 [monthly]

Recruiting NA
Mar 2023 — Apr 2024 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Jan 2023 — Mar 2023 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
University of California, San Francisco

Data source: University of California, San Francisco

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• San Francisco, United States